We are live on ! Find out more
VIVE

VIVEVE MED INC
VIVE

Delisted

VIVE was delisted on the 18th of January, 2023.

Back to rankings

17 hedge funds and large institutions have $1.91M invested in VIVEVE MED INC in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

504% more capital invested

Capital invested by funds: $316K → $1.91M (+$1.59M)

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

89% more funds holding

Funds holding: 9 → 17 (+8)

5.39% more ownership

Funds ownership: 0.65% → 6.04% (+5.4%)

Holders
17
Holders Change
+8
Holders Change %
+88.89%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
5
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$999K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$257K
3
MIH
Meitav Investment House
Israel
+$202K
4
VF
Virtu Financial
New York
+$159K
5
Citadel Advisors
Citadel Advisors
Florida
+$108K

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$120K
2
TRCT
Tower Research Capital (TRC)
New York
-$2K

VIVE Hedge Fund Activity: Q1 2021 in Review

17 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q1 2021, worth a combined $1.91M — up 504% from $316K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new VIVE positions and 2 closed out — a net gain of 8 holders — while 5 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, adding an estimated $999K. The largest seller was HRT Financial, exiting entirely with an estimated $120K sold.

  • 17 institutional investors held VIVEVE MED INC (VIVE) as of Q1 2021, up from 9 in Q4 2020.
  • Funds reported $1.91M of VIVEVE MED INC stock for Q1 2021, up 504% quarter-over-quarter.
  • 10 funds opened new VIVEVE MED INC positions in Q1 2021 and 2 closed out, a net change of +8 holders.
  • The largest VIVEVE MED INC buyer in Q1 2021 was BlackRock, an estimated $999K added.
  • The largest VIVEVE MED INC seller in Q1 2021 was HRT Financial, an estimated $120K sold.

Based on aggregated 13F filings for Q1 2021.